Nomura Holdings Inc Acadia Pharmaceuticals Inc Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $9.18 Million - $11.8 Million	-562,204 Reduced 60.59%	365,662 $6.88 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $12.2 Million - $16 Million	861,409 Added 1296.19%	927,866 $14.8 Million
Q3 2022 Nov 15, 2022	SELL	$14.11 - $18.27 $131,999 - $170,915	-9,355 Reduced 12.34%	66,457 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $986,314 - $2.06 Million	75,812 New	75,812 $1.09 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.